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Abstract: 
A one-pot simple procedure for the synthesis of uniform, ellipsoidal Eu3+-doped sodium 
lanthanum tungstate and molybdate (NaLa(XO4)2, X = W, Mo) nanophosphors, 
functionalized with carboxylate groups, is described. The method is based on a 
homogeneous precipitation process at 120 ºC from appropriate Na+, Ln3+ and tungstate or 
molybdate precursors dissolved in ethylene glycol/water mixtures containing polyacrylic 
acid. A comparative study of the luminescent properties of both luminescent materials as 
a function of the Eu3+ doping level has been performed to find the optimum 
nanophosphor, whose efficiency as X-ray computed tomography contrast agent is also 
evaluated and compared with that of a commercial probe. Finally, the cell viability and 
colloidal stability in physiological pH medium of the optimum samples have also been 
studied to assess their suitability for biomedical applications. 
Keywords: nanoparticles; NaLa(WO4)2; NaLa(MoO4)2; europium; functionalization; 
luminescence; X-ray computed tomography 
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1. Introduction  
The interest in Ln-based phosphors (Ln = lanthanide), usually consisting of 
nanoparticles made up of a crystalline host (oxides, fluorides, phosphates and vanadates 
[1]) doped with active Ln3+cations, has greatly increased during the last years because of 
their applicability as luminescent probes for several biomedical applications among 
which, imaging is the one most commonly investigated [2]. Such interest mainly arises 
from the higher chemical and optical stability of these phosphors when compared with 
other available luminescent materials along with their lower toxicity [3]. Other 
advantages of Ln-based nanoparticles include high luminescence quantum yield and 
narrow emission bands, which result in a high selectivity for bioassays [3]. 
The luminescent characteristics of this kind of materials are determined by the nature 
of the doping cations. Thus, down-shifting (emissions at lower energy than that of 
excitation) or up-converting (emissions at higher energy than that of excitation) 
phosphors can be obtained by a proper selection of the emitting cations. In the case of 
down-shifting phosphors, the most appropriated Ln doping cation for bioapplications is 
red emitting Eu3+, since possible interferences caused by the autofluorescence of tissues 
are minimized in this wavelength range [4]. Although Eu3+-based phosphors are not 
useful for in vivo applications because of the need of UV excitation, they have been used 
for many ex vivo and in vitro biomedical applications [5].  
It is important to mention that for this kind of uses, the bioprobes must fulfil several 
requirements related to: i) uniformity in size and shape, since these factors affect the 
interactions with cell and tissues [6], ii) particle size, which must be kept within the 
nanometer range, especially for in vivo applications, to control the circulation behaviour 
of the nanoparticles in the body, their biodistribution and their excretion pathway [6], iii) 
toxicity, since the nanoprobes must be obviously non-toxic and iv) colloidal stability, 
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which must be high in physiological media [7]. To meet the latter criteria, the 
nanoparticles may require surface coating with organic molecules having different 
functional groups (carboxylate, amino, imino, etc.), which confer to them a high colloidal 
stability by increasing their surface charge or by steric hindrance [8]. In addition, a high 
emission intensity is required for luminescent imaging. However, the absorption 
coefficient of the Ln3+ cations is low, which results in low intensity of the emissions [9]. 
To overcome this problem, several strategies can be adopted. One of them takes 
advantage of the large absorption coefficient of some inorganic anions, which are able to 
transfer the absorbed energy to the active Ln ions thus increasing the intensity of 
luminescence [9]. Among these anions are tungstates and molybdates, which efficiently 
absorb UV light that can be transferred to some Ln3+ ions such as Eu3+ [10-13]. In 
particular, the scheelite family having general formula MR(XO4)2  (M = Na+ or K+, R = 
rare earth cation and X = W or Mo) has been shown to be a promising host for doping 
with Ln3+ cations resulting in high efficient phosphors [14]. It should be noted that the 
composition of these phosphors confer to them an additional and useful functionality as 
contrast agent for X-ray computed tomography (CT), a commonly used technique for 
biomedical imaging [1]. The reason for that is that they contain elements with high atomic 
number (lanthanides, molybdenum and mainly tungsten), which, consequently, provide 
them with high X-ray attenuation capacity [1]. 
In spite of such advantages, the biomedical applications of MR(XO4)2-based 
compounds has been rarely addressed. Only a few reports have been found in literature 
for some members of the family like NaLa(MoO4)2 [15], NaGd(MoO4)2 [16] and 
NaGd(WO4)2 [17,18], whereas no reports have been found for NaLa(WO4)2. A possible 
reason for that might be the unavailability of synthesis methods to produce this material 
with the needed characteristics mentioned above. Most previous reported methods for the 
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synthesis of uniform NaLa(WO4)2 particles resulted in micron sized entities, [19-25] 
which do not meet the size criteria. Only Wang et al., recently reported a procedure, which 
produced Dy and Sm doped NaLa(WO4)2 nanocubes based on a solvothermal reaction 
using oleic acid as dispersing and capping agent [26]. However, the resulting particles 
were covered by oleic acid molecules making them hydrophobic and therefore, not useful 
for bioapplications, and they have to be further treated following several procedures (for 
example, a 5-min treatment with NOBF4) to remove the oleic acid cover [27]. Therefore, 
the development of synthesis procedures yielding uniform NaLa(WO4)2 nanoparticles 
doped with luminescent Ln3+ cations having colloidal stability in physiological media is 
highly desirable. 
In this work, we describe for the first time a one-pot simple procedure for the 
synthesis of uniform Eu3+-doped NaLa(WO4)2 nanophosphors with ellipsoidal shape and 
functionalized with carboxylate groups provided by polyacrylic acid (PAA). This 
polymer has been suggested as one of the most useful functional coatings for biomedical 
applications due to its high affinity to the cellular membranes [8]. The employed method 
is based on a homogeneous precipitation process at 120ºC from appropriate Na+, Ln3+ and 
tungstate precursors dissolved in ethylene glycol (EG)/water mixtures containing PAA 
molecules. We also show that this method can be easily adapted for the synthesis of 
isomorphous Eu3+-doped NaLa(MoO4)2 nanoparticles. A comparative study of the 
luminescent properties of both luminescent materials as a function of the Eu3+ doping 
level has also been conducted to find the optimum nanophosphor, whose efficiency as CT 
contrast agent is evaluated and compared with that of a commercial probe. Finally, the 
cell viability and colloidal stability in a physiological pH media of the optimum samples 
have also been studied to assess their suitability for biomedical applications. 
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2. Materials and Methods 
2.1. Materials 
Lanthanum (III) chloride hydrate (LaCl3·xH2O, Aldrich, 99%) and europium (III) 
chloride hexahydrate (EuCl3·6H2O, Aldrich 99%) were selected as Ln precursors whereas 
sodium tungstate (Na2WO4, Aldrich, ≥ 98%) and sodium molybdate (Na2MoO4, Aldrich, 
≥ 98%) were used as tungstate and molybdate source, respectively, both being also the 
Na+ source. Polyacrylic acid polymer (PAA, average Mw~1800, Aldrich) was used for 
functionalization, whereas ethylene glycol (EG, Aldrich, ≥ 99.5%) or EG/water (Milli-Q) 
mixtures were used as solvents. The colloidal stability study was performed using 2-
morpholinoethanesulfonic acid (MES, Aldrich, 99%). The commercial CT contrast agent 
used for comparison purposed was Iohexol (Sigma Aldrich, analytical standard, ≥ 95%). 
2.2. Synthesis and functionalization of NaLa(WO4)2 nanoparticles          
NaLa(WO4)2 nanoparticles were prepared according to the following procedure. 
First, LaCl3 was dissolved in ethylene glycol (2.5 cm3) under magnetic stirring while 
heating the vial at ~80ºC to facilitate the dissolution process. The resulting solution (A) 
was left to cool down to room temperature. In a separate vial, Na2MoO4 was dissolved in 
2.5 cm3 of EG or different EG/H2O mixtures (solutions B). In some experiments, different 
amounts of PAA were also added to the latter solution. Solutions A and B were then  
mixed together under magnetic stirring and the final mixtures (total volume = 5 cm3) were 
subsequently aged for 20 hours in tightly closed test tubes using an oven preheated at 
120°C. The resulting dispersions were cooled down to room temperature, centrifuged to 
remove the supernatants and washed, twice with ethanol and once with distilled water. 
Finally, the precipitates were redispersed in Milli-Q water or, for some analyses, dried at 
room temperature.  
2.3. Synthesis and functionalization of NaLa(MoO4)2 nanoparticles          
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The same procedure described above for NaLa(WO4)2 was used for the synthesis of 
NaLa(MoO4)2 nanoparticles slightly modified by substituting the tungstate precursor by 
Na2MoO4. 
2.4. Synthesis and functionalization of Eu3+-doped NaLa(XO4)2 nanoparticles (X = W or 
Mo)  
To obtain Eu3+-doped NaLa(XO4)2 nanoparticles (X = W or Mo) functionalized with 
PAA (NaLa(XO4)2@PAA), we proceeded as described above for the case of the undoped 
systems but incorporating the desired amount of the doping cations to the starting LaCl3 
solution. The total cations concentration in these solutions was kept constant (0.03 mol 
dm-3). The Eu/(Eu+La) molar ratio was varied from 3 to 27% in order to investigate the 
effects of the doping level on the luminescent properties of the precipitated nanoparticles. 
2.5.   Characterization  
The shape of the nanoparticles was examined by transmission electron microscopy 
(TEM, Philips 200CM) by depositing a droplet of an aqueous suspension of the samples 
on a copper grid coated with a transparent polymer. Particle size was measured on several 
hundreds of particles from TEM micrographs.  
The crystalline structure of the prepared particles was identified by X-ray diffraction 
(XRD, Panalytical X´Pert Pro with an X-Celerator detector). Unit cell parameters were 
determined from the XRD data (collected at intervals of 0.02° 2θ for an accumulation 
time of 1000 s) by Rietveld refinement using the X´Pert High Score Plus software. The 
crystallite size was estimated from the most intense XRD peak (200) located at 2θ  33º 
in the pattern of the NaLa(XO4)2 samples (X = W or Mo) by using the Scherrer formula.  
The infrared spectra (FTIR) of the nanophosphors diluted in KBr pellets were 
recorded in a JASCO FT/IR-6200 Fourier Transform spectrometer. Thermogravimetric 
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analyses (TGA) were performed in air at a heating rate of 10°C min-1, using a Q600 TA 
instrument.  
For a proper comparison of the luminescent properties of the nanophosphors 
containing different Eu3+ doping levels, aqueous suspensions of the nanoparticles having 
the same concentration (1 mmol dm-3) were prepared. The excitation and emission spectra 
of these dispersed samples were measured in a Horiba Jobin Yvon spectrofluorimeter 
(Fluorolog FL3-11) operating in the front face mode. Excitation and emission slits of 1 
nm and 2 nm were used, respectively, for the excitation spectra and vice versa for the 
emission ones. Measurements of lifetimes associated to the transitions of the Eu3+ cation 
were obtained from luminescence decay curves recorded in the same equipment using a 
pulsed lamp. The decay curves were registered for the most intense Eu3+ emission band 
at 610 nm. Absolute values of photoluminescence quantum yield were measured from the 
ratio between light emitted and light absorbed by the different nanophosphor powders 
using an integrating sphere in a fluorimeter (Edinburgh FLS1000). A powder tray (1 cm 
diameter) made from polytetrafluoroethylene was used as sample holder. Powder tray 
was filled with the similar amount of material and covered with a quartz lid to avoid 
spillage into the sphere. A plug made from the same material that is used for the sphere, 
also covered with a quartz lid, was used as a blank. Spectra were recorded using an 
excitation wavelength that corresponds to the maximum of the energy transfer band, 
which is 262 nm for the tungstate-based nanophosphor and 290 nm for molybdate one. 
Thus, measurements comprise processes from the absorption of UV light by the 
tungstate/molybdate matrix, the transfer to Eu3+, and the subsequent outcoupling of the 
emitted light. Typical experimental error in these measurements is 1%. 
Photographs showing the luminescence of aqueous suspensions of the Eu3+-doped 
nanophosphors were taken under illumination with an ultraviolet lamp (λ = 254 nm). 
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For the evaluation of the CT contrast efficiency, aqueous dispersions containing 
different concentrations of the optimized nanophosphors or Iohexol, in 1.5 mL Eppendorf 
tubes were prepared. The dispersions were placed in a vortex device for 2 min prior to 
analyses. Each sample (200 μL aliquot) was placed in a multiwell microplate, along with 
a Milli-Q water sample for calibration. CT images were acquired with a 
NanoSPECT/CT® (Bioscan). Acquisition parameters included a 106 mA current for a 
voltage of 65 kV, exposure time per projection of 1500 ms and 360 projections per 
rotation. The image length was 6 cm, with a pitch of 1. The total acquisition time required 
was 18 min. The image was reconstructed with Vivoquant image processing software 
(Invicro), with the exact cone beam filtered back projection algorithm and the Shepp 
Logan 98 % filter. The resulting image pixel size was uniform in three dimensions at 0.2 
mm. Images were analyzed with PMOD 3.8 software (PMOD Technologies LLC). 
Spherical volumes of interest (VOIs) of 2 mm radius were made within each sample to 
calculate the X-ray attenuation (in Hounsfield Units, HU) for each concentration. 
Average values of Milli-Q water and dispersions were used to calculate HU values in the 
images, with attenuation being 0 HU for water and –1000 HU for air. 
The colloidal stability of nanoparticles suspensions in 50 mM MES solution at 
pH=6.5 (physiological pH simulator), having a nanoparticles content of 0.5 mg cm-3, was 
monitored by analysing the particle size distribution (hydrodynamic diameter, dH) 
obtained from dynamic light scattering (DLS) measurements (Zetasizer NanoZS90, 
Malvern). 
 Cell viability was analysed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) colorimetric assay [28]. Vero cells (kidney epithelial 
cells from African green monkey) were acquired from the American Type Culture 
Collection (ATCC: CCL-81) and cultured at 37 °C in a 5% CO2 atmosphere in Dulbecco's 
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modified Eagle's medium (DMEM)  supplemented with 10% foetal bovine serum (FBS), 
2 mM glutamine and 100U cm-3 penicillin/streptomycin.  
For the MTT analysis, 5000 cells were seeded in each well of 96-well plates and grown 
for 24 h. After 24 h, the medium was replaced with fresh medium containing the 
nanoparticles in varying concentrations. After cultivation again for 24 h, 20 µL of MTT 
dye solution (5 mg cm-3 in PBS) was added to each well. After 3 h of incubation at 37 °C 
and 5% CO2, the medium was removed, the cells were washed with fresh medium, the 
plate was centrifuged at 2,500 rpm for 30 minutes, the supernatant was removed and 
formazan crystals were dissolved in 100 µL of DMSO. The absorbance of each well was 
read on a microplate reader (Biotek ELX800) at 570 nm. The relative cell viability (%) 
related to control wells containing cells without nanoparticles was calculated as 
[A]test/[A]control x100.  
 
3. Results and Discussion 
3.1. Undoped NaLa(WO4)2 nanoparticles          
As it has been amply documented, the formation of uniform particles through 
precipitation requires a specific reaction kinetics that must be found by adjusting the 
experimental conditions such as reagents concentration, temperature, reaction time, 
nature of solvent and nature of additives [29]. In this work, we fixed the reagent 
concentrations (0.03 mol dm-3 lanthanum (III) chloride and 0.16 mol dm-3 sodium 
tungstate), temperature (120ºC) and aging time (20 h) and varied the nature of the solvent 
(EG/H2O mixtures with variable EG:H2O volumetric ratio) in order to find the effect of 
this parameter on the morphological characteristics of the precipitated particles. The 
results are summarized in Table 1 and Fig. 1a-c. As observed, in pure EG, irregular and 
aggregated nanoparticles with very small size were produced (Fig. 1a). However, when 
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adding water to the EG, important differences in the morphological characteristics of the 
precipitates were detected. Thus, for an EG/H2O volumetric ratio of 4/1, well-dispersed 
ellipsoidal particles with broad size distribution in the submicrometric range were 
obtained (Fig. 1b). A further increase of the amount of water added (EG/H2O) = 3/2) gave 
rise to an increase of particle size up to the micron range, keeping the size heterogeneity 
(Fig. 1c). This behavior could be explained by the reduction of the viscosity (0.01733 
Pa∙s for ethylene glycol and 0.001 Pa∙s, for water) and the rise of the dielectric constant 
(80 for water and 37 for EG at 20°C) of the mixed solvent as increasing the amount of 
water. Thus, the dropping of viscosity would favor the diffusion process of solutes, which 
consequently accelerates particles growth, explaining the increase of particle size 
observed as increasing the amount of water. Besides, the rise of the dielectric constant of 
the solvent must result in an increase of solubility of the precursors, lowering the 
supersaturation degree and, consequently, increasing the nuclei radius according to the 
Kelvin equation [30], which might also contribute to such particle size increase. Finally, 
the higher degree of dispersion of the precipitated particles detected as increasing the 
amount of water can be also attributed to the consequent increase of the dielectric 
constant, which must give rise to a higher zeta potential value and therefore, to a higher 
repulsion between the growing particles, disfavoring their agglomeration [31]. 
We have shown in previous papers that the addition of PAA to the starting solutions 
plays an important role in the formation of nanoparticles with controlled size and shape 
of different Ln-based compounds by homogeneous precipitation, since this polymer may 
act as a capping agent [32]. We adopted this strategy here in order to reduce particle size 
down to the nanometer range and improve the size uniformity. In effect, the addition of 
increasing amounts of PAA (up to 2 mg cm-3) into the EG:H2O solution (volumetric ratio 
4/1) containing the tungstate precursor, gave rise to a progressive decrease of particle size 
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(Table 1) and to a significant increase of size homogeneity (Fig. 1d,e). A further increase 
of the amount of PAA up to 4 mg cm-3 did not have an appreciable effect on the size and 
morphology of the final nanoparticles (Fig. 1f and Table 1).  
The role played by PAA on controlling the size of the precipitated particles is 
revealed by the FTIR spectrum (Fig. 2a, red line) of the ellipsoidal nanoparticles shown 
in Fig. 1e, which are chosen from now on as a representative example. The spectrum 
displays the absorptions associated to the W-O stretching vibration of the WO42- anion 
(<1000 cm-1) [19], along with two broad bands at about 3400 and 1640 cm−1, which are 
due to absorbed water. Some other weaker bands are detected in the 1710-1400 cm-1 
region, which are not present in the spectrum corresponding to the sample synthesized 
without PAA (Fig. 2a, blue line). Such features can be attributed to the C=O stretching 
(1711 cm-1), CH2 stretching (1450 cm-1) and the symmetric (1400 cm-1) and asymmetric 
(1545 cm-1) stretching vibrations of the carboxylate ions of the PAA species, probably 
adsorbed on the particles surfaces [33]. The amount of such species was determined by 
TGA measurements (Fig. 2b). The TGA curve obtained for such functionalized sample 
showed a weight loss (4%) in the 25-300ºC range due to the release of adsorbed water 
and a further loss (3.7%) between 300 and 400ºC. The latter is absent in the TGA curve 
of a sample prepared in the absence of PAA (shown in Fig. 1b), being associated to the 
decomposition of PAA molecules.  
The presence of PAA molecules on the surface of the nanoparticles could block the 
growth of the nanoparticles, explaining their ability to decrease the final size. The fact 
that the particle size does not vary by increasing the amount of PAA above 2 mg cm-3 
suggests that this amount is sufficient to achieve a complete PAA coating on the surface 
of the nanoparticles.  
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The ellipsoidal nanoparticles shown in Fig. 1e were identified by XRD as tetragonal 
NaLa(WO4)2 (PDF 1-79-1118, ICDD 2016) as illustrated in Fig. 2c. Crystallite size 
estimated using the Scherrer formula from the (200) reflection (2θ~33°) of the XRD 
patterns of this sample was found to be lower (25 nm) than the dimensions of the 
ellipsoids, which suggests that the nanoellipsoids were polycrystalline.   
Therefore, the synthesis method developed in this work is suitable for the one-pot 
synthesis of uniform ellipsoidal NaLa(WO4)2 nanoparticles with tetragonal structure, and 
their simultaneous surface modification with PAA polymer.  
3.2. Undoped NaLa(MoO4)2 nanoparticles          
For the NaLa(MoO4)2 nanoparticles, we used the same synthesis conditions that 
yielded the NaLa(WO4)2 nanoellipsoids shown in Fig. 1e, but replacing the tungstate 
precursor for the molybdate one. Uniform particles with ellipsoidal shape were also 
obtained (Fig. 3a) in this case, although they presented a higher axial ratio (2.5) than those 
corresponding to the tungstate system (1.88) and a smaller size (115 x 45 nm). Such 
particles consisted of tetragonal NaLa(MoO4)2 (PDF 1-79-2243, ICDD 2016) (Fig. 3b). 
The crystallite size calculated using the Scherrer equation, from the width of the (200) 
reflection, was 16 nm indicating that the NaLa(MoO4)2 nanoparticles were also 
polycrystalline. FTIR spectroscopy confirmed the presence of PAA molecules on the 
particle surface (Fig. 3c), the amount of which was 4.8% by weight, as determined from 
the TGA curves (Fig. 3d). Such an amount is higher than that corresponding to the 
NaLa(WO4)2 system (3.7 %), which is in agreement with the lower surface area expected 
for the latter case, as a consequence of the higher particle size.  
3.3. Eu3+-doped NaLa(XO4)2 (X = W, Mo) nanoparticles          
Eu3+-doped NaLa(XO4)2 (X = W or Mo) nanoparticles were synthesized by using the 
experimental conditions involved in the synthesis of the undoped samples functionalized 
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with PAA (NaLa(XO4)2@PAA) shown in Figs. 1e (NaLa(WO4)2) and 3a (NaLa(MoO4)2), 
but adding the desired amounts of the Eu3+ precursor to the starting cations solutions. In 
these experiments, the total Ln concentration (0.03 mol dm-3) was kept constant and the 
doping level was varied (from 3 to 27% molar) in order to optimize the luminescent 
properties of these nanophosphors.  
It was found that the doping procedure did not produce important changes in the 
morphological characteristics of the precipitated nanoparticles whose shape was similar 
(Figs. S1 and S2) to that obtained for the undoped systems. However, a progressive 
decrease of particle size as increasing the doping level was detected (Table 2). This effect 
has also been noticed for other Ln doped nanoparticles with different composition [34], 
and may be associated with variations in the precipitation kinetics and/or the unit cell 
volume induced by the doping cations [35].   
The success of the doping process was manifested by the composition (Eu/(Eu+La) 
mol ratio) of the samples measured by ICP, which in all cases, was very close to the 
nominal values (Table 2). EDX mapping analyses revealed that the Eu3+ cations were 
homogeneously distributed across the nanoparticles as shown in Figs. 4 and S3 for the 
Eu:NaLa(WO4)2 and Eu:NaLa(MoO4)2 systems, respectively.   
The XRD patterns of the doped samples (Figs. S4 and S5) were also similar to that of 
undoped systems, indicating that they also crystallized into the tetragonal phase. No 
significant variations in crystallite size were either observed for the doped samples respect 
to those of the undoped ones (Table 3) confirming the polycrystalline character for all 
samples.  
The unit cell parameters obtained for the doped samples (Table 3) confirmed the 
incorporation of the Eu cations to the tungstate and molybdate matrices forming a solid 
solution. Thus, a progressive contraction of the unit cell was detected as increasing the 
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amount of the doping cation (Fig. 5) in agreement with the smaller radius in eightfold 
coordination of Eu3+ (1.066 Å) when compared with that of La3+ (1.16 Å) [36]. 
Finally, the FTIR spectra of all doped samples (Fig. S6) also showed weak bands in 
the 1710-1400 cm-1 region, confirming that PAA molecules also covered the doped 
nanoparticles.  
3.4. Luminescence Properties          
The excitation spectrum recorded for an aqueous suspension of the 
Eu(7%):NaLa(WO4)2@PAA nanoparticles, monitored at the most intense Eu3+ emission 
band (610 nm), is presented in Fig. 6. The spectrum displays a strong and broad excitation 
band, with maximum at 262 nm.  This band correspond to the reported an energy transfer 
(ET) process from the excited levels of WO42- group to the Eu3+ cations [24]. The 
spectrum shows, in addition, much weaker bands resulting from the f-f electronic 
transitions characteristic of the Eu3+ ions [24], the most intense appearing at 393 nm due 
to the 7F0-5L6 transition (inset in Fig. 6). 
 The excitation spectrum of an aqueous suspension of the 7% 
Eu:NaLa(MoO4)2@PAA nanoparticles (Fig. 6) was very similar to that of the tungstate 
based nanophosphor, except that the band associated to the energy transfer from the 
molybdate groups to the Eu3+ cations appeared at lower energy (290 nm), in agreement 
with the literature  [37], and showed higher intensity. The latter finding seems to manifest 
that the molybdate matrix absorbs energy and/or transfers it to the Eu3+ cations in a more 
effective way that the tungstate one.  
Upon excitation of the Eu:NaLa(WO4)2@PAA nanoparticles through the ET band 
(λex=262 nm), the emission bands characteristic of the electronic transitions from the 5D0  
to the 7FJ  (J = 1, 2, 3, and 4) levels of Eu3+ were detected (Fig. 7a). These bands were very 
similar to those detected for the Eu:NaLa(MoO4)2@PAA system (Fig. 7b), as expected, 
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since the electronic transitions of Ln3+ cations are hardly affected by crystal field. It 
should be noted that the relative intensities of the 5D0-7F2 (610 nm) and 5D0-7F1 (590 nm) 
transitions strongly depend on the local symmetry of the Eu3+ ions. Thus, the latter 
transition is magnetic-dipole allowed and insensitive to the local environment of the Eu3+ 
cations, whereas the 5D0-7F2 electric-dipole transition becomes the strongest one when 
the Eu local symmetry is lowered [38]. In our samples, the emission originated from the 
5D0-7F2 transitions is clearly dominant irrespective of the matrix, indicating that the Eu3+ 
occupies a crystallographic site in the host lattice with no inversion center as that of La3+ 
cations in the scheelite structure with S4 symmetry [39]. Such emission is responsible for 
the strong red luminescence of the samples observed in the photographs inserted in Fig. 
7, which correspond to the samples containing 20 % Eu. 
The intensity of the emissions for each system is plotted in Fig. 7c, as a function of 
the Eu content. It can be observed that in both cases, the increase of the Eu3+ doping level 
from 3% to 20%, gave rise to a progressive rise of the intensity of the emission as a 
consequence of the larger number of emission centers. However, for higher doping levels 
(27%), the intensity of luminescence remained almost unaltered. This behavior suggests 
the presence of the well-known concentration quenching effect [40], which was further 
studied by evaluating the luminescent dynamics of the samples.  
The decay curves obtained for the 5D0 → 7F2 Eu3+ transition (610 nm), after pulsed 
excitation at the ET band, as function of Eu concentration for both systems are presented 
in Figs. 8a and 8b. In all cases, the curves could be fitted by using a bi-exponential 
temporal dependence according to Equation (1):  
                                      I(t) = I01 exp(−t/τ1) + I02 exp(−t/τ2)                                  (1) 
 
where I(t) is the luminescence intensity, t is the time after excitation and τi (i = 1, 2) is 
the decay time of the i-component, with initial intensity I0i. The corresponding fitting 
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parameters are presented in Table 4. This bi-exponential behavior is common in Ln-based 
nanophosphors. The shorter lifetime values are usually associated to the transitions of Ln 
cations located on the nanoparticles outer-layers, and therefore, influenced by quenching 
processes due to interactions with solvent molecules and impurities, whereas the longer 
lifetime values are due to transitions of the Ln cations located in the bulk, and therefore, 
less affected by such quenching processes. Table 4 also shows that the relative weight of 
the long component increases with increasing doping level in both systems, suggesting 
that the relative amount of Eu3+ cations located in the bulk also increases.  
The average lifetime values, <τ>, calculated as 
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where tf  represents the time required for the luminescence signal to reach the background, 
are also included in Table 4. It is important to mention that these values (from 1106 to 
959 s, for the Eu:NaLa(WO4)2 samples; and from 861 to 655 s, for the 
Eu:NaLa(MoO4)2 samples) are much higher than those previously reported for these 
systems (from 401 to 640 s, for Eu:NaLa(WO4)2 [19, 21, 26, 41,] and from 400 to 620 
s, for Eu:NaLa(MoO4)2 [42,43]). This finding seems to indicate the higher efficiency of 
our nanophosphors.  
The <τ> values have also been plotted in Fig. 8c as a function of the Eu3+ content. 
For both systems, <τ> kept decreasing during the whole range of studied compositions, 
confirming the concentration quenching effect in such range. It should be noted that the 
increase of the emissions intensity detected when increasing the Eu content up to 20% 
can be explained by considering that the increase of luminescent centers compensates, at 
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least in part, the concentration quenching effect. Therefore, from the practical point of 
view, the samples having a 20% Eu can be considered as the optimum ones in view of 
their highest emission intensity for which, they were used for further analyses. 
Finally, the observation of Fig. 7c also reveals that the intensity of the emissions is 
clearly higher for the Eu:NaLa(MoO4)2 nanophosphors when compared with those based 
on Eu:NaLa(WO4)2, disregarding the Eu content, which is in agreement with the higher 
intensity of the energy transfer band observed for the first system (Fig. 6). To explain this 
behavior, the luminescence quantum yield (QY) of the nanophosphors is also plotted in 
Fig. 7c as a function of the Eu content. Specifically, we measured the so called overall 
quantum yield by exciting the samples through their corresponding ET bands, which 
therefore contains information on the intrinsic quantum yield as well as on the efficacy 
with which energy is transferred from the matrix to the Eu3+ cations [44]. First, it was 
observed that the QY values vs. Eu content followed a similar trend that the luminescent 
intensity for both systems, confirming that the optimum samples were those with the 
highest doping level (20 %). Interestingly, it was also found that the QY values were 
higher for the molybdate-based system than those for the tungstate one, irrespective of 
the Eu content. This behavior seems to indicate that the higher intensity of the 
Eu:NaLa(MoO4)2 nanophosphors may be due to either a higher intrinsic QY of the 
luminescence of Eu3+ in the molybdate matrix and/or to a higher efficiency of ET in  this 
matrix. These results allow concluding that, because of their better luminescence 
properties, the molybdate-based nanophosphors here developed are better candidates for 
their use as luminescent probes for bioimaging. 
 
3.5. X-ray Attenuation Properties 
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The X-ray attenuation values of aqueous suspensions containing different 
concentrations of the optimum nanophosphors (Eu(20%):NaLa(MoO4)2 and Eu 
(20%):NaLa(WO4)2) were measured and compared with aqueous suspensions containing 
the same concentrations of Iohexol, which is a clinically approved CT contrast agent. The 
corresponding CT phantom images are shown in Fig. 9a, where a higher contrast can be 
observed for the nanophosphors suspensions than for Iohexol at any concentration. The 
X-ray attenuation values, in Hounsfield units (HU), obtained from these images are 
plotted in Fig. 9b versus the nanophosphors concentration. As observed, a good linear 
correlation between the HU values and the concentration of the suspensions was obtained 
for all systems. In addition, it was observed that the slope of the line was higher for the 
Eu:NaLa(WO4)2 sample (37.1 HU/mg cm-3) than for the Eu:NaLa(MoO4)2 one (24.2 
HU/mg cm-3), and it was, in both cases, significantly higher than that of Iohexol (15.0 
HU/mg cm-3). These results are as expected since the X-ray attenuation coefficient 
increases as increasing the average atomic number of the elements constituting the sample 
[45]. This behavior confirms a superior CT imaging performance for our nanophosphors 
when compared with Iohexol, especially for the Eu:NaLa(WO4)2 case, which can be 
considered as promising CT contrast agents.  
 
 3.6. Colloidal Stability and Biocompatibility   
 The colloidal stability of the optimum nanophosphors (Eu(20%)-doped 
NaLa(WO4)2@PAA and Eu(20%)-doped NaLa(MoO4)2@PAA), was evaluated to assess 
their suitability for biomedical applications. It was observed that the hydrodynamic 
diameter (dh) obtained from DLS measurements (Fig. 10) in freshly prepared 
nanoparticles suspensions in MES buffer at physiological pH (MES 50 mM at pH=6.5), 
was only slightly higher (160 nm, for the tungstate system and 140 nm for the molybdate 
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system) than the mean particle size obtained from the TEM pictures (100 x 60 nm, for 
tungstate and 105 x 31 nm for molybdate). This behavior clearly indicates that the 
nanoparticles can be well dispersed in MES buffer without significant aggregation.  
Biocompatibility studies for both optimum nanophosphors were performed using 
Vero cells through the MTT assay [28]. The metabolic activity of the cells was measured 
after 24 hours culture and the results are shown in Fig. 11. As observed, irrespective of 
the matrix, the nanoparticles showed negligible toxicity effects with viability percentages 
as high as >90% for concentrations up to 0.3 mg cm-3. 
Therefore, in the tested conditions, our nanoparticles meet the colloidal stability and 
biocompatibility criteria required for their use in biomedical applications. 
 
4.   Conclusions 
We have developed a procedure for the synthesis, for the first time, of uniform and 
hydrophilic Eu3+-doped sodium lanthanum tungstate nanoparticles with ellipsoidal shape, 
based on the aging at 120ºC for 20 h of solutions containing, in an ethylene glycol/H2O 
mixed solvent, specific amounts of lanthanum chloride, europium chloride, sodium 
tungstate and polyacrylic acid. This polymer is essential to control particle size and shape 
and remains anchored to the nanoparticles surface, which becomes functionalized with 
carboxylate groups. This procedure is also suitable (obviously changing the tungstate by 
the molybdate precursor) for the synthesis of isostructural sodium lanthanum molybdate 
nanoparticles with similar morphological characteristics. Both kinds of phosphors emit 
intense red light when excited with UV radiation through the energy transfer band from 
the tungstate or molybdate anions to the Eu3+ cations. In both cases, the samples showing 
the most intense emission were those doped with 20 mol % Eu3+, for which they were 
considered as the optimum luminescent probes. Nevertheless, the luminescence intensity 
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of the molybdate-based samples was higher than that of the tungstate-based ones for any 
of the compositions assayed. This behaviour, probably due to either a higher intrinsic 
quantum yield of the Eu3+ luminescence in the molybdate matrix and/or to a higher 
efficiency of energy transfer in this matrix, manifests the superior performance of the 
molybdate system from the luminescent point of view. The X-ray absorption capacity of 
the tungstate-based material was higher than that of the molybdate-based one, in both 
cases being notably higher than that of a commercial probe (Iohexol), indicating that they 
are better contrast agents for X-ray computed tomography, especially, the tungstate 
system. Finally, the cell viability of both type of probes was very high and their colloidal 
stability at physiological pH was acceptable. Because of these properties, the developed 
nanomaterials may find potential uses as bifunctional probes for luminescent bioimaging 
and X-ray computed tomography. 
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Table 1. Shape and size of the particles obtained by aging at 120ºC for 20 h, EG/H2O 
(different ratios) solutions containing LaCl3 (0.03 mol dm-3), Na2WO4 (0.16 mol dm-3) 
and different amounts of PAA. Standard deviations are included in parentheses. 
Corresponding TEM micrographs are also indicated in the last column. 
EG/H2O  
v/v 
 
[PAA] 
mg cm-3 
Shape 
Length 
(nm) 
Width 
(nm) 
TEM 
5/0 0 Irregular   Fig.1a 
4/1 0 Ellipsoidal heterogeneous heterogeneous Fig. 1b 
11b1b 
3/2 0 Ellipsoidal heterogeneous heterogeneous Fig. 1c 
4/1 1 Ellipsoidal 190 (60) 95 (25) Fig. 1d 
4/1 2 Ellipsoidal 168 (20) 89 (11) Fig. 1e 
4/1 4 Ellipsoidal 162 (19) 78 (10) Fig. 1f 
 
 
Table 2. Nominal and experimental (measured by ICP) Eu/(Eu+La) molar ratios and size 
(from TEM) for the Eu:NaLa(XO4)2@PAA (X = W, Mo) nanoparticles. Standard 
deviation is included in parentheses. 
System Eu/(Eu+La) 
(% nominal) 
Eu/(Eu+La) 
(ICP) 
Length 
(nm) 
Width 
(nm) 
 0  - 168 (20) 89 (11) 
 3  3.0  150 (19) 80 (10) 
Eu:NaLa(WO4)2 7  7.4  120 (16) 70 (8) 
 14  14.6  100 (14) 60 (6) 
 20  20.8  80 (11) 55 (5) 
 27 28.1 70 (10) 40 (5) 
 0  - 115 (14) 45 (6) 
 3  2.9  106 (12) 32 (5) 
Eu:NaLa(MoO4)2 7  7.2  102 (10) 34 (5) 
 14  14.6  105 (11) 31 (6) 
 20  21.0  80 (9) 30 (5) 
 27 27.9 75 (8) 25 (5) 
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Table 3. Unit cell parameters, cell volume and crystallite size determined for the 
NaLa(XO4)2@PAA (X= W, Mo) samples doped with different amounts of Eu3+ (nominal 
values). Experimental errors are included in parentheses. 
 
 
System 
Eu/(Eu+La)  
(% nom.) 
a=b 
 (Å) 
c 
 (Å) 
Cell volume 
(Å3) 
Crystallite 
size (nm) 
 0  5.3548(3) 11.671(1) 334.6452 25 
 3   5.3526(3) 11.662(1) 334.1105 26 
Eu:NaLa(WO4)2 7  5.3494(3) 11.651(1) 333.4028 28 
 14  5.3425(3) 11.631(1) 331.9948 27 
 20  5.3364(3) 11.612(1) 330.6808 25 
 27 5.3301(3) 11.591(1) 329.2728 26 
 0 5.3447(4) 11.737(1) 335.2886 16 
 3  5.3421(3) 11.732(1) 334.8068 16 
Eu:NaLa(MoO4)2 7  5.3384(7) 11.721(1) 334.0567 16 
 14  5.3321(3) 11.701(1) 332.6703 17 
 20  5.3260(3) 11.683(1) 331.4139 16 
 27 5.3198(3) 11.662(1) 330.0708 16 
 
 
Table 4. Lifetime values (τ1 y τ2) and amplitudes (A1 y A2) corresponding to the two 
components and average lifetime (<τ>) determined, for NaLa(WO4)2@PAA and 
NaLa(MoO4)2@PAA nanoparticles doped with different amounts of Eu3+, from the decay 
curves registered for the 5D0 – 7F2 transition (610 nm). Standard errors in the calculation 
of the average lifetimes are below 1%.  
System 
Eu/(Eu+La)  
(% nominal) 
A1 τ1 (µs) A2 τ2 (µs) <τ> (µs) 
Eu:NaLa(WO4)2 
3 43 731  57 1268 1106 
7 27 457 73 1158 1069 
14 - - 100 1017 1035 
20 - - 100 1003 1005 
 27 - - 100 959 959 
Eu:NaLa(MoO4)2 
3 40 482 60 985 861 
7 32 426 68 893 807 
14 22 333 78 792 744 
20 19 315 81 744 705 
 27 13 201 87 675 655 
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Captions 
Fig. 1. TEM images of the particles obtained by aging at 120°C for 20 h solutions 
containing LaCl3 (0.03 mol dm-3) and Na2WO4 (0.16 mol dm-3) using different solvents: 
a) pure EG, b) EG/H2O (4:1) and c) EG/H2O (3:2); and using an EG/H2O mixture (4:1) 
as solvent in the presence of different amounts of PAA: d) 1 mg cm-3, e)  2 mg cm-3 and 
f) 4 mg cm-3 
Fig. 2. a) FTIR spectra of the nanoellipsoids obtained in presence (Fig. 1b) and in the 
absence  (Fig. 1e) of  PAA; b) TGA curves of the nanoparticles obtained in the presence 
(Fig. 1b) and in the absence  (Fig. 1e) of PAA; c) X-ray diffraction pattern of the 
nanoparticles shown in Fig, 1e; the PDF corresponding to the NaLa(WO4)2 tetragonal 
phase is also included. 
Fig. 3.  TEM micrograph (a), XRD pattern (b), FTIR spectrum (c) and TGA curve (d) of 
the particles obtained by aging at 120°C for 20 h solutions containing LaCl3 (0.03 mol 
dm-3), Na2MoO4 (0.16 mol dm-3) and PAA (2 mg cm-3) in a EG/H2O (4:1) mixture. The 
PDF corresponding to the NaLa(MoO4)2 tetragonal phase is also included in 3b. 
Fig. 4. EDX mapping obtained for a single particle of the Eu (20%):NaLa(WO4)2 sample.  
Fig. 5. Evolution of unit cell volume with Eu content for the Eu3+:NaLa(WO4)2@PAA 
(red) and Eu3+:NaLa(MoO4)2@PAA (blue) nanoparticles. 
Fig. 6. Excitation spectra of Eu3+(7%)-doped NaLa(WO4)2@PAA (red line) and Eu3+ 
(7%)-doped NaLa(MoO4)2@PAA (blue line) nanoparticles. The inset is a magnification 
of the 350-425 nm spectral region. 
Fig. 7. Emission spectra of the of the Eu3+:NaLa(WO4)2@PAA (a) and 
Eu3+:NaLa(MoO4)2@PAA (b) nanoparticles with different Eu contents. The insets 
correspond to photographs of the Eu(20%)-doped NaLa(WO4)2@PAA (a) and Eu(20%)-
doped NaLa(MoO4)2@PAA (b) nanoparticles suspensions taken under UV (254 nm) 
illumination, c) Integrated intensity of the emissions (balls) and overall quantum yield 
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(stars) of the Eu3+:NaLa(WO4)2@PAA (red) and Eu3+:NaLa(MoO4)2@PAA (blue) 
nanophosphors as a function of the Eu3+ doping level. Lines are guides for the eye. 
Fig. 8. Temporal decays for the 5D0→7F2 transition (610 nm) of the Eu-doped 
NaLa(WO4)2@PAA (a) and NaLa(MoO4)2@PAA (b) nanoparticles with different Eu 
content and average lifetime values calculated from such decays (c). 
Fig. 9. CT phantom images (a) and HU values (b) for the Eu(20%):NaLa(WO4)2@PAA 
and  Eu(20%):NaLa(MoO4)2@PAA samples and for Iohexol at different concentrations 
in water.  
Fig. 10. Hydrodynamic diameter (dh) obtained from DLS measurements for the 
Eu(20%):NaLa(MoO4)2@PAA and Eu(20%):NaLa(MoO4)2@PAA nanoparticles 
dispersed in 50 mM MES solution at pH = 6.5. 
Fig. 11. Cell vialibility of the Eu(20%):NaLa(MoO4)2@PAA and 
Eu(20%):NaLa(MoO4)2@PAA nanoparticles. 
  
32 
 
 
 
 
 
Fig. 1 
  
33 
 
 
 
Fig. 2 
34 
 
 
Fig. 3 
  
35 
 
 
 
 
Fig. 4 
 
Fig. 5 
 
36 
 
 
Fig. 6 
 
37 
 
 
Fig. 7 
 
 
  
38 
 
 
Fig. 8 
  
39 
 
 
 
 
Fig. 9 
 
 
 
40 
 
 
Fig. 10 
 
Fig. 11 
